172 related articles for article (PubMed ID: 32767702)
61. [Possible contribution of disseminated Mycobacterium shigaense infection to development of splenic marginal zone lymphoma].
Hatsuse M; Daikoku Y; Taminishi Y; Fuchida SI; Takemura Y; Okano A; Murakami S; Shimazaki C
Rinsho Ketsueki; 2018; 59(7):878-883. PubMed ID: 30078797
[TBL] [Abstract][Full Text] [Related]
62. [Progress on Treatment of Splenic Marginal Zone Lymphoma-Review].
Wu L; Tian C; Zhang YZ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):600-603. PubMed ID: 28446319
[TBL] [Abstract][Full Text] [Related]
63. Emergency Splenectomy in a Patient with Splenic Marginal Zone Lymphoma, Acute Portal Vein Thrombosis, and Chronic Viral Hepatitis B.
Karpova R; Gorbunov A; Mnatsakanyan M; Pogromov A; Sokolova I; Shumskaya Y; Russkova K; Chernousov K; Momatyuk D
J Blood Med; 2021; 12():431-434. PubMed ID: 34135652
[TBL] [Abstract][Full Text] [Related]
64. [Splenic marginal zone lymphoma complicated by cold agglutinin disease].
Ochi K; Yokoyama K; Ohno N; Ota Y; Tojo A
Rinsho Ketsueki; 2017; 58(2):132-137. PubMed ID: 28321090
[TBL] [Abstract][Full Text] [Related]
65. Splenic small B-cell lymphoma with predominant red pulp involvement: a diffuse variant of splenic marginal zone lymphoma?
Mollejo M; Algara P; Mateo MS; Sánchez-Beato M; Lloret E; Medina MT; Piris MA
Histopathology; 2002 Jan; 40(1):22-30. PubMed ID: 11903595
[TBL] [Abstract][Full Text] [Related]
66. Non-MALT marginal zone lymphoma.
Thieblemont C; Davi F; Noguera ME; Brière J
Curr Opin Hematol; 2011 Jul; 18(4):273-9. PubMed ID: 21577105
[TBL] [Abstract][Full Text] [Related]
67. Transformation risk and associated survival outcome of marginal zone lymphoma: A nationwide study.
Sun X; Li H; Yang Y; Wu Y; Kang K; Liu Q; Luo R; Wang L; Zhao A; Niu T
Ann Hematol; 2024 Mar; ():. PubMed ID: 38459154
[TBL] [Abstract][Full Text] [Related]
68. Splenic marginal zone lymphoma.
Oscier D; Owen R; Johnson S
Blood Rev; 2005 Jan; 19(1):39-51. PubMed ID: 15572216
[TBL] [Abstract][Full Text] [Related]
69. Optimal Rituximab Monotherapy in Splenic Marginal Zone Lymphoma (SMZL): A Case Report and Brief Review.
Guan RY; Tang XR; Huang ZF; Du J; Fu XH; Lu G; Mou WW
Recent Pat Anticancer Drug Discov; 2023 Nov; ():. PubMed ID: 37937574
[TBL] [Abstract][Full Text] [Related]
70. Splenic marginal zone lymphoma: disease features and management.
Matutes E
Expert Rev Hematol; 2013 Dec; 6(6):735-45. PubMed ID: 24168526
[TBL] [Abstract][Full Text] [Related]
71. Treatments and Outcomes in Stage I Extranodal Marginal Zone Lymphoma in the United States.
Alderuccio JP; Florindez JA; Reis IM; Zhao W; Lossos IS
Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33918801
[TBL] [Abstract][Full Text] [Related]
72. Distinctive clinical and histological features of Waldenström's macroglobulinemia and splenic marginal zone lymphoma.
Arcaini L; Varettoni M; Boveri E; Orlandi E; Rattotti S; Zibellini S; Merli M; Lucioni M; Rizzi S; Gotti M; Morello L; Pascutto C; Paulli M
Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):103-5. PubMed ID: 21454204
[TBL] [Abstract][Full Text] [Related]
73. Treatment of splenic marginal zone B-cell lymphoma: an analysis of 81 patients.
Thieblemont C; Felman P; Berger F; Dumontet C; Arnaud P; Hequet O; Arcache J; Callet-Bauchu E; Salles G; Coiffier B
Clin Lymphoma; 2002 Jun; 3(1):41-7. PubMed ID: 12141954
[TBL] [Abstract][Full Text] [Related]
74. Blastic transformation after splenectomy in a patient with nonvillous splenic marginal zone lymphoma with p53 overexpression: a case report.
Kakinoki Y; Kubota H; Sakurai H; Sato T; Tokusashi Y
Int J Hematol; 2005 Jun; 81(5):417-20. PubMed ID: 16158823
[TBL] [Abstract][Full Text] [Related]
75. Epidemiology and survival outcomes of patients with primary intraocular lymphoma: a population-based analysis.
He LF; Zhang JD; Chen XX; Wei RL
BMC Ophthalmol; 2022 Dec; 22(1):486. PubMed ID: 36514001
[TBL] [Abstract][Full Text] [Related]
76. Concurrent Splenic Marginal Zone B Cell Lymphoma and Metastatic Pancreatic Adenocarcinoma Diagnosed on Splenectomy for Suspected Splenic Abscess.
Fernandez K; Cheung LH; Balasinkam S; Taddesse-Heath L
Cureus; 2023 Feb; 15(2):e35541. PubMed ID: 37007330
[TBL] [Abstract][Full Text] [Related]
77. Multi-Database Description of Primary Splenic Diffuse Large B-Cell Lymphoma.
Byrd KP; Vontela NR; McCullar B; Martin MG
Anticancer Res; 2017 Dec; 37(12):6839-6843. PubMed ID: 29187463
[TBL] [Abstract][Full Text] [Related]
78. Dysregulation of global microRNA expression in splenic marginal zone lymphoma and influence of chronic hepatitis C virus infection.
Peveling-Oberhag J; Crisman G; Schmidt A; Döring C; Lucioni M; Arcaini L; Rattotti S; Hartmann S; Piiper A; Hofmann WP; Paulli M; Küppers R; Zeuzem S; Hansmann ML
Leukemia; 2012 Jul; 26(7):1654-62. PubMed ID: 22307176
[TBL] [Abstract][Full Text] [Related]
79. [Different treatment regimens for primary central nervous system lymphoma:based on SEER database].
Yang CW; Ren XH; Jiang HH; Li MX; Zhao XZ; Zhu QH; Cui Y; Lin S
Zhonghua Wai Ke Za Zhi; 2021 Jan; 59(1):52-58. PubMed ID: 33412634
[No Abstract] [Full Text] [Related]
80. Sites of extranodal involvement are prognostic in patients with diffuse large B-cell lymphoma in the rituximab era: an analysis of the Surveillance, Epidemiology and End Results database.
Castillo JJ; Winer ES; Olszewski AJ
Am J Hematol; 2014 Mar; 89(3):310-4. PubMed ID: 24273125
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
